Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.60B P/E - EPS this Y 7.90% Ern Qtrly Grth -
Income -134.66M Forward P/E -40.61 EPS next Y 38.30% 50D Avg Chg 9.00%
Sales 314.71M PEG -5.69 EPS past 5Y - 200D Avg Chg 38.00%
Dividend N/A Price/Book 7.30 EPS next 5Y 8.00% 52W High Chg -7.00%
Recommedations 1.90 Quick Ratio 4.53 Shares Outstanding 50.19M 52W Low Chg 85.00%
Insider Own 3.51% ROA -7.96% Shares Float 47.72M Beta 1.10
Inst Own 104.16% ROE -27.16% Shares Shorted/Prior 3.49M/3.69M Price 74.72
Gross Margin 75.99% Profit Margin -42.79% Avg. Volume 543,237 Target Price 106.55
Oper. Margin -44.46% Earnings Date May 1 Volume 656,030 Change -2.58%
About Glaukos Corporation

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Glaukos Corporation News
04/16/24 Glaukos Announces the Release of its 2023 Sustainability Report
04/15/24 Here's Why You Should Retain Glaukos (GKOS) Stock for Now
04/12/24 Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?
04/11/24 Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)?
04/10/24 Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
04/08/24 Glaukos (GKOS) Hits 52-Week High: What's Driving the Stock?
04/04/24 Glaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS
04/03/24 Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
04/01/24 Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
03/22/24 Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?
03/04/24 Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR
02/27/24 Glaukos Corp Director Mark Foley Sells 4,560 Shares
02/23/24 Glaukos Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
02/22/24 Glaukos Corporation (NYSE:GKOS) Q4 2023 Earnings Call Transcript
02/22/24 Glaukos (GKOS) Q4 Earnings Miss Estimates, Revenues Rise Y/Y
02/22/24 Q4 2023 Glaukos Corp Earnings Call
02/21/24 Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates
02/21/24 Glaukos Corp (GKOS) Reports Increased Sales but Widening Losses in Q4 and Full Year 2023
02/21/24 Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
02/21/24 Is Glaukos Corporation (NYSE:GKOS) Trading At A 41% Discount?
GKOS Chatroom

User Image JFDI Posted - 9 hours ago

$GKOS

User Image IN0V8 Posted - 1 week ago

$GKOS Truist Securities raises target price to $120 from $110

User Image FlynancialAnalyst Posted - 1 week ago

$ITGR $3.88B mc $XLV medical devices name showing majors RS to the sector last wk with a tight wkly close just under ATHs on above avg volume Fully institutionally owned, only 196 watchers on Stocktwits #HiddenGem $PRCT $GKOS $TMDX TrendEdge.app/asset/ITGR

User Image TraderIsaac Posted - 1 week ago

$GKOS Daily Chart bull flag.

User Image TraderIsaac Posted - 1 week ago

$GKOS Green Line Breakout with bull flag on daily below Livermore level.👀

User Image erevnon Posted - 1 week ago

Mizuho maintains Glaukos $GKOS at Neutral and raises the price target from $85 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image insiderbuyingselling Posted - 1 week ago

$GKOS new insider selling: 59801 shares. http://insiderbuyingselling.com/?t=GKOS

User Image InsiderPeek Posted - 2 weeks ago

$GKOS CFO Thurman Alex R. sold 1.6k shares for $163.3k (ownership down 3.02%) insiderpeek.com/company/GKOS

User Image Stock_Titan Posted - 2 weeks ago

$GKOS Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1 https://www.stocktitan.net/news/GKOS/glaukos-to-release-first-quarter-2024-financial-results-after-market-n3ec3tiewuhp.html

User Image insiderbuyingselling Posted - 2 weeks ago

$GKOS new insider selling: 1634 shares. http://insiderbuyingselling.com/?t=GKOS

User Image Doozio Posted - 2 weeks ago

$GKOS a MNDY $ pattern in 🧠⏰??

User Image technicalmarketcycles Posted - 2 weeks ago

$XLV $GKOS $TMDX $PRCT

User Image victorcastro Posted - 2 weeks ago

$XLE $BTC.X $ODFL $WFC $GKOS kool, congrats, cheers

User Image erevnon Posted - 2 weeks ago

Truist Securities reiterates Glaukos $GKOS at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image FlynancialAnalyst Posted - 2 weeks ago

$GKOS pushing thru $100 for first time ever. #WaveGoodbye

User Image FlynancialAnalyst Posted - 2 weeks ago

$SLP $952M mc $XLV healthcare + $XLK tech name back on watch following last wk's bullish engulfing on volume at key $40 level Institutional ownership has been steadily rising despite the choppy range. 78.67% currently vs 75% 2yrs ago. Short float % falling precipitously 👀👍 $GKOS $PRCT

User Image JFDI Posted - 2 weeks ago

$GKOS $PRCT $TMDX $XLV $DXCM

User Image FlynancialAnalyst Posted - 2 weeks ago

$GKOS $4.79B mc $XLV medical devices name showing RS to the sector last wk with an ATH wkly close on volume, just under key $100 level Institutional ownership has been rising rapidly over the past 2 yeras... looks ready to go! $PRCT $TMDX

User Image insiderbuyingselling Posted - 2 weeks ago

$GKOS new insider selling: 750 shares. http://insiderbuyingselling.com/?t=GKOS

User Image insiderbuyingselling Posted - 2 weeks ago

$GKOS new insider selling: 400 shares. http://insiderbuyingselling.com/?t=GKOS

User Image insiderbuyingselling Posted - 2 weeks ago

$GKOS new insider selling: 474 shares. http://insiderbuyingselling.com/?t=GKOS

User Image erevnon Posted - 3 weeks ago

Stifel reiterates Glaukos $GKOS at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image briefingcom Posted - 3 weeks ago

$GKOS: Glaukos announces the U.S. Centers for Medicare and Medicaid Services has assigned a unique, permanent Healthcare Common Procedure Coding System J-code for iDose TR 75 mcg, a prostaglandin analog indicated for the reduction of intraocular pressure in patients with ocular hypertension or open-angle glaucoma https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240403070844GKOS&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image Stock_Titan Posted - 3 weeks ago

$GKOS Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant) https://www.stocktitan.net/news/GKOS/glaukos-receives-permanent-j-code-for-i-dose-r-tr-travoprost-oo6ren076x7y.html

User Image Stock_Titan Posted - 3 weeks ago

$GKOS Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting https://www.stocktitan.net/news/GKOS/glaukos-to-present-numerous-scientific-abstracts-at-the-2024-doezp4pzpf60.html

User Image erevnon Posted - 03/25/24

Citigroup maintains Glaukos $GKOS at Buy and raises the price target from $107 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image erevnon Posted - 1 month ago

Truist Securities reiterates Glaukos $GKOS at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image swingingtech Posted - 1 month ago

$SLYG, $ASTH, $PRFT, $GKOS https://wallstreetwaves.com/how-the-parts-add-up-slyg-headed-for-93/

User Image insiderbuyingselling Posted - 1 month ago

$GKOS new insider selling: 6250 shares. http://insiderbuyingselling.com/?t=GKOS

User Image insiderbuyingselling Posted - 02/27/24

$GKOS new insider selling: 140245 shares. http://insiderbuyingselling.com/?t=GKOS

Analyst Ratings
Mizuho Neutral Apr 11, 24
Truist Securities Buy Apr 8, 24
Stifel Buy Apr 3, 24
Citigroup Buy Mar 25, 24
Truist Securities Buy Mar 22, 24
Wells Fargo Overweight Feb 22, 24
Needham Buy Feb 22, 24
Needham Buy Feb 16, 24
Truist Securities Buy Dec 29, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jan 29 Sell 94.12 9,476 891,881 119,802 01/31/24
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jan 29 Option 39.1 9,476 370,512 129,278 01/31/24
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jan 22 Sell 94.01 524 49,261 119,802 01/24/24
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jan 22 Option 39.1 524 20,488 120,326 01/24/24
Thurman Alex R. SVP & CHIEF FINANCIA.. SVP & CHIEF FINANCIAL OFFICER Jan 18 Sell 90.77 583 52,919 54,618 01/22/24
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jan 16 Sell 89.17 4,890 436,041 119,802 01/18/24
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jan 16 Option 30.92 4,890 151,199 124,692 01/18/24
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jan 12 Sell 89.01 110 9,791 119,802 01/16/24
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jan 12 Option 30.92 110 3,401 119,912 01/16/24
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jan 08 Sell 83.9 60,115 5,043,648 55,835 01/10/24
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jan 08 Option 7.28 60,115 437,637 55,950 01/10/24
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jan 02 Option 7.28 95,000 691,600 150,835 01/03/24
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jan 02 Sell 77.61 95,000 7,372,950 55,835 01/03/24
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Dec 21 Sell 84.75 25,000 2,118,750 120,001 12/22/23
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Dec 21 Option 41.69 25,000 1,042,250 145,001 12/22/23
Thurman Alex R. SVP & CHIEF FINANCIA.. SVP & CHIEF FINANCIAL OFFICER Dec 21 Sell 85.14 583 49,637 55,242 12/22/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Dec 21 Sell 85.27 79,685 6,794,740 55,835 12/22/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Dec 21 Option 7.28 79,685 580,107 55,836 12/22/23
Thurman Alex R. SVP & CHIEF FINANCIA.. SVP & CHIEF FINANCIAL OFFICER Dec 15 Sell 79.80 1,270 101,346 55,825 12/18/23
Stapley Marc Director Director Dec 14 Sell 75.98 16,250 1,234,675 31,316 12/18/23
Stapley Marc Director Director Dec 14 Option 19.64 16,250 319,150 47,566 12/18/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Dec 14 Sell 79.08 90,000 7,117,200 55,835 12/18/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Dec 14 Option 7.28 90,000 655,200 115,835 12/18/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Oct 02 Sell 72.6 45,000 3,267,000 54,785 10/04/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Oct 02 Option 7.28 45,000 327,600 99,785 10/04/23
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jul 14 Sell 78.34 42,099 3,298,036 120,484 07/18/23
Gilliam Joseph E PRESIDENT & COO PRESIDENT & COO Jul 14 Option 37.7 42,099 1,587,132 162,583 07/18/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jul 14 Sell 78.08 30,000 2,342,400 673,963 07/18/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jul 14 Option 7.28 30,000 218,400 703,963 07/18/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jul 07 Sell 70.7 13,573 959,611 673,963 07/11/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jul 07 Option 7.28 13,573 98,811 687,403 07/11/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jul 03 Sell 69.89 31,427 2,196,433 673,963 07/06/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jul 03 Option 7.28 31,427 228,789 678,990 07/06/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jun 28 Sell 70.19 26,810 1,881,794 673,963 06/30/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jun 28 Option 7.28 26,810 195,177 700,773 06/30/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jun 08 Sell 70.02 3,190 223,364 673,963 06/12/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jun 08 Option 7.28 3,190 23,223 677,153 06/12/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jun 06 Option 7.28 25,000 182,000 691,345 06/08/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jun 06 Sell 66.72 25,000 1,668,000 673,963 06/08/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jun 02 Sell 60 142 8,520 673,963 06/05/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO Jun 02 Option 7.28 142 1,034 674,105 06/05/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO May 19 Sell 60.11 8 481 673,963 05/23/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO May 19 Option 7.28 8 58 673,970 05/23/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO May 17 Sell 60.11 12,282 738,271 673,963 05/19/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO May 17 Option 7.28 12,282 89,413 685,625 05/19/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO May 15 Sell 60.02 7,568 454,231 673,963 05/17/23
Burns Thomas William CHAIRMAN & CEO CHAIRMAN & CEO May 15 Option 7.28 7,568 55,095 677,667 05/17/23
Kliman Gilbert H Director Director Aug 04 Sell 53.01 3,362 178,220 08/08/22
Gilliam Joseph E CFO, SVP Corporate D.. CFO, SVP Corporate Development May 05 Option 36.31 15,000 544,650 72,739 05/05/21
Gilliam Joseph E CFO, SVP Corporate D.. CFO, SVP Corporate Development May 05 Sell 94.15 20,000 1,883,000 52,739 05/05/21